Top Fully Remote Biotech Companies (78)

At Inato, we’re on a mission to accelerate the pace of medical innovation by bringing clinical research to each and every patient, regardless of who they are and where they live. Our platform, made to connect community-based research centers to trials across the globe, aims to create greater visibility, access, and engagement across a more diverse population of doctors and...

Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.

Prenosis is an artificial intelligence company enabling precision medicine in acute care. It leverages the Immunix precision-medicine platform to develop new precision-medicine tools and implement them in real time within clinical workflows. The company’s offerings include ImmunoScore, which received FDA De Novo marketing authorization in 2024, supporting Prenosis’s mission to bring personalized, data-informed care to patients and clinicians at the...

Inductive Bio brings the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.

Zymeworks (NASDAQ:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks’ suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks’ lead clinical candidate, zanidatamab, is a novel Azymetric™ HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials...

Aravas Inc. was a clinical-stage specialty pharmaceutical company focused on developing and commercializing product candidates for patients with rare respiratory diseases, including cystic fibrosis and pulmonary alveolar proteinosis. Its pipeline included Molgradex and AeroVanc, and it operated in the specialty-pharmaceutical segment focused on the respiratory system. Following its April 2017 business combination with Savara, Aravas became a wholly owned subsidiary.

WHO WE ARE: AgelessRx is a first-of-its-kind longevity telemedicine platform. Our mission is to help people live longer, healthier lives by offering scientifically-backed prescription therapies and prevention plans to help safely lower the risk of age-related diseases. We’re a spirited group of longevity enthusiasts who believe aging should no longer be treated as a dreadful inevitability but instead as a...

Artos AI develops a generative-AI platform for biopharma and life-sciences organizations. Its software helps clinical development, medical writing, CMC, and regulatory teams create, manage, trace, and collaborate on documents used in regulatory submissions, including INDs, NDAs, and BLAs. By turning structured and unstructured data into submission-ready materials, Artos aims to shorten development timelines and bring treatments to patients faster and...

The AI In-Silico Lab, powered by Bio Foundation Models — enabling virtual experiments for target ID, RNA design, and patient stratification.

Novotech is a leading Asia-Pacific biotech specialist CRO and consists of two operating brands, "Novotech" and "PPC". Novotech is a full-service clinical CRO with labs, phase I facilities, and drug development consulting services.

We are a group of engineers and innovators, working together to create and launch ingenious products and companies today for a sustainable tomorrow. Our vision is to paradigm shift R&D in the country, making it a competitive driver in the transformation of the national economy. With a mission to seed intellectual potential for a sustainable future, eiGroup embraces an integrated approach...

BridgeBio Oncology Therapeutics (BBOT) is a clinical-stage biopharmaceutical company developing bioavailable small-molecule inhibitors for cancers driven by RAS and PI3K pathways. Its research explores novel approaches to the RAS signaling pathway and creates RAS-targeted small molecules, including approaches to inhibit KRAS in both active and inactive states and RAS-driven PI3Kα activation. The company aims to deliver well-tolerated medicines with greater...

Blueprint is a health optimization and longevity company founded by Bryan Johnson. It focuses on using data-driven protocols and advanced science to maximize human longevity, offering a comprehensive system of measurements, protocols, and therapies. By leveraging biological data and rigorous experimentation, the company makes Bryan Johnson's personal anti-aging and health optimization protocol accessible to the public through a range of...

Headquartered in San Francisco, Deffai is an AI-native VC-backed seed-stage startup building an AI platform for simulating FDA regulatory intelligence, built together with former FDA reviewers. We help therapeutics companies and their investors anticipate regulatory outcomes. We are ambitious builders with diverse technical backgrounds building vertical AI solutions in a deeply regulated space. Work closely with former FDA decision-makers to redefine...

Vow is a cultured meat company, founded and operated in Sydney, Australia. We’re a multidisciplinary team of scientists, technologists and designers, all working together to make sustainable food both irresistible and available to billions of people.

We are making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today.

Thrivelab is a telehealth-based provider of evidence-based hormone and testosterone balancing programs as well as natural bioidentical products to alleviate age-related symptoms and restore youthful vitality.

Merge Labs is a research lab with the long-term mission of bridging biological and artificial intelligence to maximize human ability, agency and experience. Join us: merge.io/careers

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.

As agile partners to life science enterprises, we offer personalized solutions that advance clinical and commercial operations from development to delivery. We combine customized precision, uncompromising quality, and intuitive expertise to define new standards in sourcing, supply chain, and storage services. Our newly architected company builds on a rich legacy of experience across life science services: Kitting by Therapak Biorepository & Archiving...